Renal Denervation: Where Are We?

July 1, 2015 - Medscape

Helping patients reach their blood pressure goals can be difficult in some cases. As a result, there has been increasing interest in developing device-based therapeutic strategies that target the sympathetic nervous system, including catheter-based renal denervation (RDN) devices. A resurgent interest in renal denervation has helped spur multiple start-up companies with newer technologies to successfully accomplish RDN [including MAF-1 portfolio company Ablative Solutions]. One innovation involves catheters that facilitate microneedle delivery of guanethidine or ethanol. These have shown excellent promise, and may offer the advantages of shorter procedure times and less patient discomfort. more*

* Please note that to view the entire article (and all other content on Medscape from WebMD), a one-time registration is needed, which is free of charge.